IBM Retirement Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,900
Closed -$224K 64
2022
Q1
$224K Sell
2,900
-140
-5% -$10.8K 0.03% 480
2021
Q4
$269K Sell
3,040
-2,092
-41% -$185K 0.03% 460
2021
Q3
$397K Hold
5,132
0.03% 483
2021
Q2
$428K Sell
5,132
-1,006
-16% -$83.9K 0.03% 473
2021
Q1
$463K Sell
6,138
-545
-8% -$41.1K 0.03% 473
2020
Q4
$586K Sell
6,683
-937
-12% -$82.2K 0.04% 395
2020
Q3
$580K Buy
7,620
+1,648
+28% +$125K 0.05% 321
2020
Q2
$737K Buy
5,972
+36
+0.6% +$4.44K 0.09% 178
2020
Q1
$502K Buy
5,936
+1,578
+36% +$133K 0.09% 217
2019
Q4
$368K Sell
4,358
-121
-3% -$10.2K 0.07% 256
2019
Q3
$302K Sell
4,479
-47
-1% -$3.17K 0.06% 303
2019
Q2
$388K Buy
4,526
+36
+0.8% +$3.09K 0.07% 250
2019
Q1
$399K Buy
4,490
+88
+2% +$7.82K 0.08% 230
2018
Q4
$375K Sell
4,402
-229
-5% -$19.5K 0.09% 209
2018
Q3
$449K Sell
4,631
-499
-10% -$48.4K 0.1% 223
2018
Q2
$483K Sell
5,130
-464
-8% -$43.7K 0.1% 223
2018
Q1
$454K Buy
5,594
+2,992
+115% +$243K 0.08% 267
2017
Q4
$232K Hold
2,602
0.04% 322
2017
Q3
$242K Hold
2,602
0.04% 300
2017
Q2
$236K Buy
2,602
+696
+37% +$63.1K 0.04% 298
2017
Q1
$223K Sell
1,906
-14,137
-88% -$1.65M 0.06% 303
2016
Q4
$1.4M Sell
16,043
-68
-0.4% -$5.92K 0.06% 303
2016
Q3
$1.49M Sell
16,111
-3,122
-16% -$289K 0.08% 277
2016
Q2
$1.56M Buy
19,233
+346
+2% +$28.1K 0.06% 324
2016
Q1
$1.62M Sell
18,887
-20,896
-53% -$1.8M 0.06% 318
2015
Q4
$4.17M Buy
39,783
+2,737
+7% +$287K 0.08% 260
2015
Q3
$4M Sell
37,046
-2,073
-5% -$224K 0.08% 247
2015
Q2
$5.35M Buy
39,119
+3,580
+10% +$490K 0.1% 206
2015
Q1
$4.43M Buy
35,539
+152
+0.4% +$18.9K 0.08% 263
2014
Q4
$3.2M Buy
35,387
+1,588
+5% +$144K 0.06% 334
2014
Q3
$2.47M Sell
33,799
-2,845
-8% -$208K 0.05% 385
2014
Q2
$2.27M Buy
36,644
+740
+2% +$45.8K 0.04% 440
2014
Q1
$2.44M Sell
35,904
-19,962
-36% -$1.36M 0.05% 402
2013
Q4
$3.93M Sell
55,866
-2,321
-4% -$163K 0.05% 386
2013
Q3
$4.2M Sell
58,187
-7,746
-12% -$559K 0.06% 362
2013
Q2
$3.68M Buy
+65,933
New +$3.68M 0.05% 424